Glaucoma News and Research RSS Feed - Glaucoma News and Research

While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
Mice study shows stem cell infusion could help treat glaucoma

Mice study shows stem cell infusion could help treat glaucoma

An infusion of stem cells could help restore proper drainage for fluid-clogged eyes at risk for glaucoma. That's the upshot of a study led by a Veterans Affairs and University of Iowa team. [More]
Scientists measure eye pressure of sleeping patients to find link between OSAS and glaucoma

Scientists measure eye pressure of sleeping patients to find link between OSAS and glaucoma

Scientists at Hokkaido University have successfully measured the eye pressure of sleeping patients with obstructive sleep apnea syndrome for the first time, finding an unexpected correlation with glaucoma. [More]
New, minimally invasive procedure may be effective for patients with FED

New, minimally invasive procedure may be effective for patients with FED

A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant. [More]
New eye test could help detect glaucoma earlier than current techniques

New eye test could help detect glaucoma earlier than current techniques

UNSW Australia scientists have developed a testing protocol that identifies the blinding eye disease glaucoma four years earlier than current techniques. [More]
Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients. [More]
Scientists succeed in restoring multiple key aspects of vision in mice

Scientists succeed in restoring multiple key aspects of vision in mice

Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals. [More]
Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana is having a positive impact on the bottom line of Medicare's prescription drug benefit program in states that have legalized its use for medicinal purposes, according to University of Georgia researchers in a study published today in the July issue of Health Affairs. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
TKCI Srujana Innovation Award launched to combat corneal blindness

TKCI Srujana Innovation Award launched to combat corneal blindness

The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop’ at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India. [More]
SeeAbility calls for free eye tests for people with learning disabilities in England

SeeAbility calls for free eye tests for people with learning disabilities in England

In a report launched in parliament tomorrow (Tuesday 5th July) national disability charity SeeAbility will say NHS England’s national sight testing and funding system is letting down the one million people with learning disabilities in England. [More]
Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Do you really need to get your eyes checked—even if you haven't noticed any vision problems or eye-related symptoms? More than half of routine eye examinations in asymptomatic patients lead to a change in vision prescription or other changes in care, according to a study in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
Transorbital ACS can improve vision in patients with glaucoma, optic nerve damage

Transorbital ACS can improve vision in patients with glaucoma, optic nerve damage

Vision loss due to glaucoma or optic nerve damage is generally considered irreversible. Now a new prospective, randomized, multi-center clinical trial demonstrates significant vision improvement in partially blind patients after 10 days of noninvasive, transorbital alternating current stimulation. [More]
FDA approves Raindrop Near Vision Inlay device for patients with presbyopia

FDA approves Raindrop Near Vision Inlay device for patients with presbyopia

The U.S. Food and Drug Administration today approved the Raindrop Near Vision Inlay, a device implanted in the cornea (the clear, front surface) of one eye to improve near vision in certain patients with presbyopia. [More]
Pain reliever appears to help preserve vision in animal model of retinal degeneration

Pain reliever appears to help preserve vision in animal model of retinal degeneration

A pain medicine that potently activates a receptor vital to a healthy retina appears to help preserve vision in a model of severe retinal degeneration, scientists report. [More]
Eye donations: what stops people? An interview with Rory Passmore

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate. [More]
JAMA edition provides summary of FSMB policy recommendations about marijuana in patient care

JAMA edition provides summary of FSMB policy recommendations about marijuana in patient care

The Journal of the American Medical Association has published in its online edition a summary of new policy adopted by the Federation of State Medical Boards that provides recommendations about marijuana in patient care and a cautionary note advising actively licensed physicians to abstain from using marijuana while practicing medicine. [More]
Researcher employs high-resolution imaging, mechanical mapping to gauge structural integrity of cornea

Researcher employs high-resolution imaging, mechanical mapping to gauge structural integrity of cornea

A biomedical engineer at the University of Houston is developing new techniques to map the structural integrity of the human cornea, work that could lead to more effective therapies for degenerative corneal disease. [More]
Scientists identify gene linked to severe glaucoma in children

Scientists identify gene linked to severe glaucoma in children

Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children. [More]
Scientists developing cost-effective retinal scanner for early diagnosis of glaucoma, diabetic retinopathy

Scientists developing cost-effective retinal scanner for early diagnosis of glaucoma, diabetic retinopathy

A European group of scientists are working on the development of a breakthrough, compact, cost-effective retinal scanner that will play a key role in targeting the early diagnosis of retinal diseases that are worldwide leading causes of blindness. [More]
FDA takes action against websites that illegally sell unapproved prescription drugs

FDA takes action against websites that illegally sell unapproved prescription drugs

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, announced that it took action this week against 4,402 websites that illegally sell potentially dangerous, unapproved prescription drugs to U.S. consumers. [More]
Advertisement